Citius Oncology (CTOR) Long-Term Debt Issuances (2023 - 2024)

Citius Oncology (CTOR) posted quarterly Long-Term Debt Issuances of $325311.0 for Q2 2024, up 62.66% quarter-over-quarter from $200000.0 in Q1 2024.

Citius Oncology (CTOR) Long-Term Debt Issuances (2023 - 2024) Analysis & Trends

Citius Oncology (CTOR) has reported Long-Term Debt Issuances for 2 consecutive years, with $325311.0 the latest figure, recorded in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Citius Oncology	80.25 Mn	80.25 Mn	1.00 Mn	-

Download Data